A spoon full of sugar makes the medicine go down, but so does Orbis Biosciences. Orbis’ technology creates long-acting, taste-masked, format-flexible pharmaceutical products for improved compliance. According to the Centers for Disease Control the direct cost of medication non-adherence is...
You are here
ORBIS BIOSCIENCES, INC.
Company Information
Information
UEI: N/A
# of Employees: 7
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Precision Microspheres for Transtympanic Delivery of Ganciclovir for CMV Infection
Amount: $224,963.00PROJECT SUMMARY Current approaches to treat sensorineural hearing loss SNHL in newborns suffering from congenital cytomegalovirus CMV infection rely on off label systemic antiviral therapy requi ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Precision Betamethasone Microspheres for Transtympanic Delivery & SSNHL Treatment
Amount: $1,498,841.00DESCRIPTION provided by applicant New treatment options are needed for inner ear disorders including Meniereandapos s disease sensorineural hearing loss autoimmune inner ear disease and tinnitus ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
Single-injection, self-contained booster vaccine
Amount: $99,069.00Vaccination is a particularly powerful weapon in the fight against wide-spread livestock disease. Commercially available vaccines, however, are often difficult and costly for livestock producers to us ...
SBIRPhase I2014Department of Agriculture -
Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric
Amount: $1,336,086.00DESCRIPTION provided by applicant New dosage forms are needed to address the shortcomings of current practice with regard to administration of medications to pediatric populations Specifically in ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
First Generation of Controlled-Release Bacteriocins/Anti-Microbials
Amount: $491,330.00Combat ration Intermediate Moisture (IM) products currently use low pH and water content (aw) to discourage bacterial growth. The long-term goal of this SBIR project is to maintain the microbial stab ...
SBIRPhase II2013Department of Defense Army -
Expanding Precision Particle Fabrication Technology for the Widespread Control of
Amount: $1,698,318.00DESCRIPTION provided by applicant A critical need currently exists in the pharmaceutical market for microparticles that can accurately and effectively control the release of poorly water soluble compo ...
SBIRPhase II2013Department of Health and Human Services National Institutes of Health -
First Generation of Controlled-Release Bacteriocins/Anti-Microbials
Amount: $149,216.00Combat ration Intermediate Moisture (IM) products use low pH and water content (aw) to discourage bacterial growth. The long-term goal of this proposal is to maintain the microbial stability of ratio ...
SBIRPhase I2012Department of Defense Army -
Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran
Amount: $287,056.00DESCRIPTION (provided by applicant): Current approaches to treat sudden sensorineural hearing loss (SSNHL) do not maintain inner ear drug concentrations within an appropriate therapeutic window for su ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric
Amount: $216,020.00DESCRIPTION (provided by applicant): Pediatric drug development presents many unique challenges in the effective treatment of diseases in children, from adequate dosing information and pediatric-speci ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
Multi-day Pain Management Therapy with Novel Injectable Formulation
Amount: $253,678.00DESCRIPTION (provided by applicant): Our long term goal is to widespread the use of PPF technology for promoting effective production of drug-encapsulating microparticles with uniform size and physica ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health
